Chidamide represses MYC expression and might improve survival for patients with double expressor lymphoma.

导出 OA

翻译打印收藏纠错

作者： Pengpeng,Liu ^[1] ; Xiaohang,Hang ^[2] ; Jianjun,Li ^[1] ; Lei,Zhao ^[2] ; Weiping,Liu ^[3] ; Jie,Ji ^[1] ; Yu,Wu ^[1] ; Xudong,Wan ^[2] ; Xiao,Shuai ^[1] ; Yong,Guo ^[1] ; Bing,Xiang ^[1] ; Jiazhuo,Liu ^[1] ; Jie,Huang ^[1] ; Zhigang,Liu ^[1] ; Li,Hou ^[1] ; Chong,Chen ^[2] ; Yu,Liu ^[2] ; Ting,Liu ^[1]

作者单位： Department of Hematology, Institute of Hematology, West China Hospital, Sichuan University Chengdu 610041, Sichuan, China. ^[1] State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University Chengdu 610041, Sichuan, China. ^[2] Department of Pathology, West China Hospital, Sichuan University Chengdu 610041, Sichuan, China. ^[3]

关键词 Chidamide HDAC inhibitor MYC double expressor lymphoma epigenetics

DOI 10.62347/GIIR3351

PMID 39005667

发布时间 2024-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交